Navigation Links
GERO's Wearable 2.0 Platform to Improve Performance of Activity Trackers
Date:1/8/2014

Las Vegas, NV (PRWEB) January 08, 2014

GERO Corporation today announced the launch of a collaborative effort within the Human Locomotome project to gather and analyze the data of 50,000 Fitbit, Jawbone, and Nike Fuelband users to advance early detection of chronic disease. Chronic diseases are the leading source of health care spending in the United States.

"Locomotor activity, measured by wearable accelerometers, has recently emerged as the single source of an unprecedented volume of continuous high-resolution data characterizing the day-to-day, around-the-clock physiological conditions of millions of people," said Vera Kozyr, co-founder of GERO. "We launched the Human Locomotome project together with our scientists to develop technology for early stage diagnostics by analyzing movement activity. We hope to make the information stable, reliable and accessible."

GERO Lab is a proprietary "crowd-research" wearable 2.0 platform used to collect data and involve people and partners in the study. Ultimately, the GERO Lab platform could help existing activity trackers improve product compliance.

GERO Lab will be able to take advantage of the expected growth in the wearable fitness devices market, expected to reach 90 million units globally by 2017, and another 80 million health-related ones, according to leading research firm ABI (Source: February 2012).

GERO recently conducted a study with 3000 Fitbit users, which confirmed the great potential for the GERO platform. Key takeaways of this study include:
Motor activity contains signatures of particular chronic deceases (metabolic, psychiatric, psychological).
Low-resolution trackers (e.g. Fitbit, Jawbone, etc) can also be used with GERO's mathematical model with sufficient tracking time.
GERO already detects particular health conditions with accuracy.

People who want to contribute their data to the 50K research study may sign up at http://getgero.com

Some of the chronic diseases that can be detected through locomotor activity include diabetes, hypertension, Alzheimer’s and depression. The company hopes its information will make possibly earlier interventions with an eye toward prevention.

About GERO

Moscow-based GERO was founded to develop a new technology platform using mathematical models to identify potential risks for age-related diseases through analysis of everyday movement. Data is being gathered from existing motion trackers, and as the technology evolves, users will have access to its analysis of their personal data, discovering early indicators of specific metabolic, psychiatric and neurological conditions. Armed with this knowledge, people can make health and lifestyle choices to preserve quality of life.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11463292.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring
2. Global Wearable Medical Technology Market 2012 - 2016 : Worldwide Industry Latest Market Share, Growth, Size,Trends , Strategy And Forecast Research Report 2016
3. Phronetic Technologies Announces First Prenatal Smart Wearable Technology; StimElation is Poised for Production
4. Wearable Electronics Market to Reach $8.36 Billion by 2018 at a CAGR of 17.7% - New Report by MarketsandMarkets
5. Wearable Electronics & Smart Textiles Technology Expert Interview - New Announcement by MarketsandMarkets
6. Wearable artificial lung to be developed at Pitt through $3.4 million grant
7. Klingg, the Wearable Magnetic Earphone Cord Holder is Released by Mokao Design
8. Wearable cameras provide new insight into lifestyle behaviors and health
9. 2014 Mint Green Bridesmaid Dresses From Good Platform iFitDress.com
10. RURO Announces a New Version of its LIMS platform Limfinity™ - Version 4.2
11. USAFact’s New RapidFACT Screening Platform Will Launch with Multiple Website Facelifts Tied to Both Old and New Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... Peter ... the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to Texas as a part of its national Swirl: A Wine Tasting Event ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American College of ... its recently formed Corporate Roundtable, a group of individuals and organizations whose collective ... , Canyon Ranch is a unique collection of lifestyle-based immersion vacation settings and ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American Board of Multiple ... for the discomforts and hidden dangers of foot fungus, particularly in the warm ... risk for developing fungal infections on the feet or toenails, the Board says. ...
(Date:9/19/2017)... ... September 19, 2017 , ... Leonard I. Linkow, DDS, DMSC, sets a new ... Xlibris on July of 2014). This book details the recent advances and techniques in ... benefit people who have lost all of their natural teeth . , In ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent review ... as the number one company for hearing aids, ranking it higher ... other brands. ... Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, state-of-the-art, ...
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 ... D.C. offering free MRI brain scans to the public.Where:  ... be parked at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology: